Inpatient Right Heart Catheterization Across Payers and Hospital Settings in US Hospitalizations With Sarcoidosis and Pulmonary Hypertension Codes, 2018–2023
Journal of Medicine, Surgery, and Public Health · 2026-11 · 100261
DOI: 10.1016/j.glmedi.2026.100261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicine, Surgery, and Public Health, 2026-11. Verfasst von Lucy Zheng und 5 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Right heart catheterization characterizes pulmonary hypertension in sarcoidosis. Whether its coded inpatient use varies by payer and hospital setting is unknown.
Methods
We analyzed adult 2018–2023 US National Inpatient Sample hospitalizations in a repeated cross-sectional study. Eligible hospitalizations had sarcoidosis and selected pulmonary hypertension or pulmonary heart disease codes. The outcome was right heart catheterization coded during the stay. Survey-weighted logistic regression adjusted for age, sex, income quartile, elective admission, sarcoidosis manifestations, Elixhauser condition count, discharge year, and hospital bed size. Risk differences were calculated from standardized probabilities, with bootstrap confidence intervals.
Results
Among 11,529 hospitalizations (weighted, 57,645), right heart catheterization was coded in 953 (8.27%). The primary model included 11,371 hospitalizations. Compared with private insurance, adjusted odds ratios were 0.55 (95% confidence interval, 0.47–0.66) for Medicare and 0.65 (0.51–0.83) for Medicaid. Compared with urban teaching hospitals, estimates were 0.68 (0.52–0.87) for urban nonteaching and 0.38 (0.23–0.62) for rural hospitals. Risk differences were −4.72 and −3.63 percentage points for Medicare and Medicaid and −2.58 and −5.14 percentage points for urban nonteaching and rural hospitals, respectively. Estimates were similar across sensitivity analyses.
Conclusions
Right heart catheterization was coded less often for Medicare and rural hospitalizations than for privately insured and urban teaching hospitalizations. Because clinical indication, prior testing, and disease severity were unavailable, the findings do not establish underuse, inappropriate care, or causation.
Zitieren
APA
Zheng, L., Zheng, J., Deb, M., Tan, W., Tan, S., & Lee, M. (2026). Inpatient Right Heart Catheterization Across Payers and Hospital Settings in US Hospitalizations With Sarcoidosis and Pulmonary Hypertension Codes, 2018–2023. Journal of Medicine, Surgery, and Public Health, 100261. https://doi.org/10.1016/j.glmedi.2026.100261
Vancouver
Zheng L, Zheng J, Deb M, Tan W, Tan S, Lee M. Inpatient Right Heart Catheterization Across Payers and Hospital Settings in US Hospitalizations With Sarcoidosis and Pulmonary Hypertension Codes, 2018–2023. Journal of Medicine, Surgery, and Public Health. 2026:100261. doi:10.1016/j.glmedi.2026.100261
BibTeX
@article{Zheng2026,
author = {Zheng, Lucy and Zheng, Jacob and Deb, Mrittika and Tan, Wenchy and Tan, Samuel and Lee, Maximillian},
title = {Inpatient Right Heart Catheterization Across Payers and Hospital Settings in US Hospitalizations With Sarcoidosis and Pulmonary Hypertension Codes, 2018–2023},
journal = {Journal of Medicine, Surgery, and Public Health},
year = {2026},
pages = {100261},
doi = {10.1016/j.glmedi.2026.100261}
}
EUVIMED